Built to help voters quickly verify how officials vote — district first, party second. All information is sourced from official public records.
HR. 1561 · 119th Congress

ALERT Communities Act

In committee

This bill has not become law. Status shown reflects the latest official action.

See what this could mean for your district

Save your district in Account to view district-specific context for this bill.

Bill details

Introduced: 2/25/2025
Status: Referred to the House Committee on Energy and Commerce.
Bill ID: 119hr1561
Latest action: Referred to the House Committee on Energy and Commerce.

Summary

Introduced in House

Advancing Lifesaving Efforts with Rapid Test strips for Communities Act or the ALERT Communities Act This bill establishes programs and requirements to advance the development and usage of test strips that detect the presence of certain hazardous drugs (e.g., fentanyl, xylazine). Currently, the Substance Abuse and Mental Health Services Administration provides grants to government entities to train and provide authorized equipment to first responders and other relevant personnel for emergency treatment of opioid overdoses. The bill expands these grants to include rapid response test strips for detecting the presence of fentanyl, xylazine, and other synthetic opioids or emerging substances in people or within other drugs. Additionally, the bill requires the Department of Health and Human Services (HHS) to publish guidance and standards for test strip manufacturers to support the development, evaluation, and authorization of test strips. Also, HHS must conduct a study and report to Congress on how the availability and usage of test strips and similar equipment impacts the frequency of overdoses and participation in substance use disorder treatment.

Source: BILLSUM · Summary date: 2/25/2025

District impact notes

1 notes
NEUTRAL
3/26/2026

The ALERT Communities Act promotes the development and use of drug detection test strips for hazardous substances. • This policy could enhance local emergency response capabilities to drug-related incidents, potentially impacting public health outcomes. • Local first responders and health services may receive additional resources and training related to the use of these test strips. • There may be questions about the effectiveness and reliability of the test strips, which could affect their acceptance and implementation in the community. AI-generated from official bill summary and plain-English note; verify with official text.

Related votes

Roll calls that reference this bill in official data.

0 roll calls
No related roll calls found yet for this bill.

Primary sources

Official links to verify details. (No interpretation.)

Summary source label: BILLSUM
About this data
  • OurCongress is non-partisan by design. We do not add political interpretation or advocacy.
  • Bill data and official summaries come from GovInfo and Congress.gov. Some bills do not have published summaries yet.
  • District impact notes (when shown) are AI-generated from official bill metadata/summaries to improve readability. They are not official government language.
  • This page updates automatically via a daily ingestion pipeline.

About this data

Non-partisan by design
OurCongress provides plain-English context without endorsements, political interpretation, or advocacy.
Official sources
Data is sourced from official government records (e.g., Congress.gov, GovInfo, Clerk of the House, and the U.S. Senate).
AI-generated text
Some sections may be AI-generated from official summaries/metadata to help readability. AI output can be imperfect—verify with primary sources.
Last updated: 3/26/2026Source: BILLSUMBill: 119hr1561Learn more →